miR-1296-5p decreases ERBB2 expression to inhibit the cell proliferation in ERBB2-positive breast cancer

BACKGROUND: The tumor suppressive role of miR-1296 is observed in triple negative breast cancer (TNBC). However, the effect of miR-1296-5p in ERBB2-positive breast cancers remains obscure. METHODS: Whether ERBB2 was the target gene of the miR-1296-5p was predicted by online software, and determined...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Gang, He, Mingfeng, Yin, Yin, Yan, Ting, Cheng, Wenfang, Huang, Zebo, Zhang, Lan, Zhang, Huo, Liu, Ping, Zhu, Wei, Zhu, Yichao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655974/
https://www.ncbi.nlm.nih.gov/pubmed/29089858
http://dx.doi.org/10.1186/s12935-017-0466-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655974/
https://www.ncbi.nlm.nih.gov/pubmed/29089858
http://dx.doi.org/10.1186/s12935-017-0466-y

Ejemplares similares